SCHEMBL26090385

SCHEMBL26090385

Cc1c(C#N)cc(C(=O)O)c(CBr)c1Br

nearest known ligand 0.38

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.38
HSD17B10 Q99714 2/20 0.38
L3MBTL1 Q9Y468 2/20 0.35
SMN1; SMN2 Q16637 4/20 0.35
ALDH1A1 P00352 4/20 0.33
GAA P10253 3/20 0.33
MEN1 O00255 1/20 0.33
MAPT P10636 1/20 0.33
KMT2A Q03164 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
NOTUM Q6P988 1/20 0.33
HTT P42858 1/20 0.33
HPGD P15428 1/20 0.33
AURKA O14965 1/20 0.32
TPX2 Q9ULW0 1/20 0.32
IMPDH2 P12268 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3115448 0.75 XDH (0.38) KDM4EHSD17B10ALDH1A1NOTUMHPGD
SCHEMBL6645692 0.72 MEN1 (0.38) KDM4EHSD17B10ALDH1A1GAAMEN1
SCHEMBL25381638 0.72 KDM4E (0.40) KDM4EHSD17B10SMN1; SMN2ALDH1A1NOTUM
SCHEMBL11520043 0.70 KDM4E (0.44) KDM4EHSD17B10L3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL26089714 0.69 AURKA (0.43) KDM4EHSD17B10L3MBTL1SMN1; SMN2ALDH1A1
SCHEMBL28863755 0.69 LCK (0.44) KDM4EHSD17B10L3MBTL1SMN1; SMN2GAA
SCHEMBL14645847 0.69 KDM4E (0.46) KDM4EHSD17B10L3MBTL1SMN1; SMN2GAA
SCHEMBL26087614 0.69 NOTUM (0.46) KDM4EHSD17B10L3MBTL1SMN1; SMN2GAA
SCHEMBL31454973 0.69 KDM4E (0.44) KDM4EHSD17B10ALDH1A1MEN1KMT2A
SCHEMBL27994109 0.69 KDM4E (0.48) KDM4EHSD17B10ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023069720-A1 COMPOUNDS THAT MEDIATE PROTEIN DEGRADATION AND METHODS OF USE THEREOF MONTE ROSA THERAPEUTICS, INC. (US) 2023-04-27 WO disclosed